293480 — Hana Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapContrarian

Annual cashflow statement for Hana Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	28,014	24,307	22,333	21,250	8,778
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	8,524	9,667	7,921	4,669	10,198
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-16,645	-9,585	-19,496	-8,337	-20,956
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	25,655	30,884	18,404	25,298	9,176
Capital Expenditures	-34,810	-35,771	-14,683	-13,208	-31,182
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-686	-736	2,789	1,587	1,205
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-35,496	-36,508	-11,894	-11,621	-29,977
Financing Cash Flow Items	-590	3	-2.36	0	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-4,090	11,557	-17,635	-6,807	22,130
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-13,931	5,933	-11,123	7,092	1,324